Literature DB >> 21740003

Sterol transfer between cyclodextrin and membranes: similar but not identical mechanism to NPC2-mediated cholesterol transfer.

Leslie A McCauliff1, Zhi Xu1, Judith Storch1.   

Abstract

Niemann--Pick C disease is an inherited disorder in which cholesterol and other lipids accumulate in the late endosomal/lysosomal compartment. Recently, cyclodextrins (CD) have been shown to reduce symptoms and extend lifespan in animal models of the disease. In the present studies we examined the mechanism of sterol transport by CD using in vitro model systems and fluorescence spectroscopy and NPC2-deficient fibroblasts. We demonstrate that cholesterol transport from the lysosomal cholesterol-binding protein NPC2 to CD occurs via aqueous diffusional transfer and is very slow; the rate-limiting step appears to be dissociation of cholesterol from NPC2, suggesting that specific interactions between NPC2 and CD do not occur. In contrast, the transfer rate of the fluorescent cholesterol analogue dehydroergosterol (DHE) from CD to phospholipid membranes is very rapid and is directly proportional to the acceptor membrane concentration, as is DHE transfer from membranes to CD. Moreover, CD dramatically increases the rate of sterol transfer between membranes, with rates that can approach those mediated by NPC2. The results suggest that sterol transfer from CD to membranes occurs by a collisional transfer mechanism involving direct interaction of CD with membranes, similar to that shown previously for NPC2. For CD, however, absolute rates are slower compared to NPC2 for a given concentration, and the lysosomal phospholipid lysobisphosphatidic acid (LBPA) does not stimulate rates of sterol transfer between membranes and CD. As expected from the apparent absence of interaction between CD and NPC2, the addition of CD to NPC2-deficient fibroblasts rapidly rescued the cholesterol accumulation phenotype. Thus, the recent observations of CD efficacy in mouse models of NPC disease are likely the result of CD enhancement of cholesterol transport between membranes, with rapid sterol transfer occurring during CD--membrane interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21740003      PMCID: PMC4281486          DOI: 10.1021/bi200574f

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

Review 1.  Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation.

Authors:  T Irie; K Uekama
Journal:  J Pharm Sci       Date:  1997-02       Impact factor: 3.534

Review 2.  Lipid traffic: floppy drives and a superhighway.

Authors:  Joost C M Holthuis; Tim P Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2005-03       Impact factor: 94.444

3.  Mechanism of cholesterol transfer from the Niemann-Pick type C2 protein to model membranes supports a role in lysosomal cholesterol transport.

Authors:  Sunita R Cheruku; Zhi Xu; Roxanne Dutia; Peter Lobel; Judith Storch
Journal:  J Biol Chem       Date:  2006-04-10       Impact factor: 5.157

4.  Sterol, protein and lipid trafficking in Chinese hamster ovary cells with Niemann-Pick type C1 defect.

Authors:  Nina H Pipalia; Mingming Hao; Sushmita Mukherjee; Frederick R Maxfield
Journal:  Traffic       Date:  2006-12-07       Impact factor: 6.215

5.  Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux.

Authors:  P G Yancey; W V Rodrigueza; E P Kilsdonk; G W Stoudt; W J Johnson; M C Phillips; G H Rothblat
Journal:  J Biol Chem       Date:  1996-07-05       Impact factor: 5.157

6.  Fatty acid transfer from liver and intestinal fatty acid-binding proteins to membranes occurs by different mechanisms.

Authors:  K T Hsu; J Storch
Journal:  J Biol Chem       Date:  1996-06-07       Impact factor: 5.157

7.  Cyclodextrins and carrier systems.

Authors:  D Duchêne; D Wouessidjewe; G Ponchel
Journal:  J Control Release       Date:  1999-11-01       Impact factor: 9.776

8.  A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats.

Authors:  U Vollmer; B W Müller; J Peeters; J Mesens; B Wilffert; T Peters
Journal:  J Pharm Pharmacol       Date:  1994-01       Impact factor: 3.765

9.  Hydroxypropylcyclodextrins in parenteral use. I: Lipid dissolution and effects on lipid transfers in vitro.

Authors:  T Irie; K Fukunaga; J Pitha
Journal:  J Pharm Sci       Date:  1992-06       Impact factor: 3.534

Review 10.  Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies.

Authors:  Raphael Zidovetzki; Irena Levitan
Journal:  Biochim Biophys Acta       Date:  2007-04-06
View more
  19 in total

1.  Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.

Authors:  Jonathan B Johnston; Arti A Singh; Anaelle A Clary; Chiung-Kuan Chen; Patricia Y Hayes; Sharon Chow; James J De Voss; Paul R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

2.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

3.  Accumulation of ordered ceramide-cholesterol domains in farber disease fibroblasts.

Authors:  Natalia Santos Ferreira; Michal Goldschmidt-Arzi; Helena Sabanay; Judith Storch; Thierry Levade; Maria Gil Ribeiro; Lia Addadi; Anthony H Futerman
Journal:  JIMD Rep       Date:  2013-07-12

4.  Cyclodextrin mediates rapid changes in lipid balance in Npc1-/- mice without carrying cholesterol through the bloodstream.

Authors:  Anna M Taylor; Bing Liu; Yelenis Mari; Benny Liu; Joyce J Repa
Journal:  J Lipid Res       Date:  2012-08-14       Impact factor: 5.922

Review 5.  Insights into the mechanisms of sterol transport between organelles.

Authors:  Bruno Mesmin; Bruno Antonny; Guillaume Drin
Journal:  Cell Mol Life Sci       Date:  2013-01-03       Impact factor: 9.261

6.  Multiple Surface Regions on the Niemann-Pick C2 Protein Facilitate Intracellular Cholesterol Transport.

Authors:  Leslie A McCauliff; Zhi Xu; Ran Li; Sarala Kodukula; Dennis C Ko; Matthew P Scott; Peter C Kahn; Judith Storch
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

Review 7.  Molecular pathways for intracellular cholesterol accumulation: common pathogenic mechanisms in Niemann-Pick disease Type C and cystic fibrosis.

Authors:  Nicholas L Cianciola; Cathleen R Carlin; Thomas J Kelley
Journal:  Arch Biochem Biophys       Date:  2011-09-05       Impact factor: 4.013

8.  Cholesterol homeostatic responses provide biomarkers for monitoring treatment for the neurodegenerative disease Niemann-Pick C1 (NPC1).

Authors:  Brett Tortelli; Hideji Fujiwara; Jessica H Bagel; Jessie Zhang; Rohini Sidhu; Xuntian Jiang; Nicole M Yanjanin; Roopa Kanakatti Shankar; Nuria Carillo-Carasco; John Heiss; Elizabeth Ottinger; Forbes D Porter; Jean E Schaffer; Charles H Vite; Daniel S Ory
Journal:  Hum Mol Genet       Date:  2014-06-25       Impact factor: 6.150

9.  Synthesis, characterization, and evaluation of pluronic-based β-cyclodextrin polyrotaxanes for mobilization of accumulated cholesterol from Niemann-Pick type C fibroblasts.

Authors:  Christopher J Collins; Leslie A McCauliff; Seok-Hee Hyun; Zhaorui Zhang; Lake N Paul; Aditya Kulkarni; Klaus Zick; Mary Wirth; Judith Storch; David H Thompson
Journal:  Biochemistry       Date:  2013-04-30       Impact factor: 3.162

Review 10.  Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin.

Authors:  Jean E Vance; Barbara Karten
Journal:  J Lipid Res       Date:  2014-03-24       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.